Education
About Us
Working with TipRanks
Follow Us
CareRx (TSE:CRRX)
TSX:CRRX
CRRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$1.71 - C$3.24
Previous CloseN/A
Volume3.32K
Average Volume (3M)53.31K
Market Cap
C$184.62M
Enterprise ValueC$261.75M
Total Cash (Recent Filing)C$8.69M
Total Debt (Recent Filing)C$81.87M
Price to Earnings (P/E)―
Beta0.14
Next Earnings
Nov 05, 2025EPS Estimate
0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding63,062,954
10 Day Avg. Volume35,254
30 Day Avg. Volume53,314
Financial Highlights & Ratios
PEG Ratio1.33
Price to Book (P/B)1.47
Price to Sales (P/S)0.34
P/FCF Ratio4.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$4.42Price Target Upside48.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Bed GrowthInfrastructure improvements provide good visibility for acceleration in bed growth.
Operational ImprovementsRevenue per bed increased 3.5% year over year, showing operational improvements.
Bears Say
Quarterly RevenueRevenue per bed in the quarter was lower than in the previous quarter, affected by the number of days in the quarter.
Revenue PerformanceThe company posted a small miss on revenues and EBITDA due to lower than forecast revenue per bed.
CareRx News
CRRX FAQ
What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was C$1.71 and its highest was C$3.24 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is C$184.62M.
When is CareRx’s upcoming earnings report date?
CareRx’s upcoming earnings report date is Nov 05, 2025 which is in 60 days.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Jul 30, 2025. The company reported C$0.01 earnings per share for the quarter, missing the consensus estimate of C$0.011 by >-C$0.001.
Is CareRx overvalued?
According to Wall Street analysts CareRx’s price is currently Undervalued.
Does CareRx pay dividends?
CareRx does not currently pay dividends.
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.04.
How many shares outstanding does CareRx have?
CareRx has 63,062,954 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of C$0.01 in its last earnings report, missing expectations of C$0.011. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in TSE:CRRX
CareRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$4.42 (48.32% Upside)
C$4.42 (48.32% Upside)
Insider Transactions
Sold Shares
Worth C$9.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
66.48%
12-Months-Change
Fundamentals
Return on Equity
-2.17%
Trailing 12-Months
Asset Growth
-0.13%
Trailing 12-Months
Company Description
CareRx
CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.
CRRX Stock 12 Month Forecast
Average Price Target
C$4.42
▲(48.32% Upside)
Technical Analysis
Extendicare
―
Sienna Senior Living
―
Medical Facilities
―
WELL Health Technologies Corp
―
Premier Health of America Inc
―
Ownership Overview
26.27% Insiders
―
Mutual Funds
― Other Institutional Investors
73.73% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---